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Pseudomonas aeruginosa and Candida albicans are disparate microbial species, but both are known to be opportunistic
pathogens frequently associated with nosocomial infections. The aim of this study was to provide a better understanding of
the interactions between these microorganisms in dual-species bioﬁlms. Several bacteriophage-resistant P. aeruginosa phe-
notypes have been isolated and were used in dual-species mixed-bioﬁlm studies. Twenty-four and 48 h mixed-bioﬁlms were
formed using the isolated phenotypes of phage-resistant P. aeruginosa and these were compared with similar experiments
using other P. aeruginosa strains with a deﬁned lipopolysaccharide (LPS) deﬁciency based on chromosomal knockout of
speciﬁc LPS biosynthetic genes. Overall, the results showed that the variants of phage-resistant P. aeruginosa and LPS
mutants were both less effective in inhibiting the growth of C. albicans in mixed-bioﬁlms compared to the wild-type strains
of P. aeruginosa. Conversely, the proliferation of P. aeruginosa was not inﬂuenced by the presence of C. albicans. In con-
clusion, the ability of strains of P. aeruginosa to inhibit the formation of a bioﬁlm of C. albicans appears to be correlated
with the LPS chain lengths of phenotypes of P. aeruginosa, suggesting that LPS has a suppressive effect on the growth of
C. albicans.
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Introduction
Bacteria and fungi co-inhabit a wide variety of environ-
ments and the interactions between them can result in
substantial medical and economic impacts (Hogan &
Kolter 2002; Wargo & Hogan 2006). Pseudomonas aeru-
ginosa, a Gram-negative bacterium, and Candida albi-
cans, a dimorphic fungus, are two important
opportunistic pathogens frequently identiﬁed as the major
causes of nosocomial infections (Pierce 2005; de Bentz-
mann & Plésiat 2011). P. aeruginosa is the etiologic
agent for many severe nosocomial infections including
bacteremia, wound infections, pneumonia, urinary tract
infections, and intra-abdominal sepsis (Van Delden & Ig-
lewski 1998; Christian van 2007; Driscoll et al. 2007;
Mittal et al. 2009). C. albicans is known to cause a wide
variety of both superﬁcial and severe systemic diseases
like infections of the skin, oral cavity and esophagus,
gastrointestinal tract, urogenital and vascular systems
(Molero et al. 1998; Calderone & Fonzi 2001). Co-infec-
tion by P. aeruginosa and C. albicans is not uncommon,
particularly in the cases of respiratory tract infections in
critically ill patients who are using mechanical ventila-
tion devices. These infections are frequently associated
with the formation of a microbial bioﬁlm inside the
endotracheal tubes (Nseir & Ader 2009). Recent studies
revealed pathogenic interactions between the two
microorganisms, whereby the morphology and virulence
of C. albicans were signiﬁcantly affected by the presence
of P. aeruginosa. A quorum-sensing molecule, 3-oxo-
C12 homoserine lactone, produced by P. aeruginosa,
apparently inﬂuences the development of the ﬁlamentous
form of C. albicans. Intriguingly, while P. aeruginosa
forms a dense bioﬁlm on ﬁlamentous C. albicans that
leads to the killing of the fungus, this bacterial species
neither binds to nor kills yeast-forms of C. albicans
(Hogan & Kolter 2002; Hogan et al. 2004; McAlester
et al. 2008; Nseir & Ader 2009).
Bacteriophages (phages) are viruses that speciﬁcally
infect and lyse bacteria. Frequently, during bacterial
infection, there is an increase in phage-resistant mutants
and, since the lipopolysaccharides (LPS) are frequently
identiﬁed as phage receptors in a bacterial host, phage
resistance can be linked to changes in the chain length
of LPS (Filippov et al. 2011). It has also been reported
that the LPS from various bacterial species exerted vari-
able effects on the inhibition of bioﬁlms of C. albicans
(Bandara et al. 2009; Bandara, Lam, et al. 2010; Bandara
et al. 2013), indicating that LPS plays a critical role in
suppressing the proliferation of the fungal pathogen in
bioﬁlm communities of mixed species.
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The inhibition of bioﬁlms of C. albicans due to the
presence of P. aeruginosa is not clearly deﬁned. The
present work aimed to provide a better understanding of
the interaction between P. aeruginosa and C. albicans in
dual-species bioﬁlms and, therefore, phage-resistant
phenotypes of P. aeruginosa and LPS mutants were used
to evaluate their inﬂuence on the ability of C. albicans
to form bioﬁlms.
Materials and methods
Bacteria, fungi, bacteriophage and culture conditions
The Pseudomonas and Candida strains used in this work
are listed in Table 1. All strains were grown at 37 °C in
Yeast Peptone Dextrose (YPD) medium, which is
composed of 10 g l−1 of yeast extract (Merck), 20 g l−1 of
peptone (Merck) and 20 g l−1 of dextrose (Merck). Solid
YPD medium also contained 1.2% w/v of agar (Merck)
and the soft agar top-layer contained 0.6% w/v of agar.
Bacteriophages, phiIBB-PAA2 and phiIBB-PAP21, were
isolated from hospital efﬂuents provided by Hospital de
São João (Porto, Portugal) (Pires et al. 2011). All
procedures related to the isolation and production of
phages were performed with Tryptic Soy Broth (Merck)
or Tryptic Soy Agar (TSA, Merck). To obtain lysates from
bacterial cultures, sonication using a medium-sized probe
(Ultrasonic Processor) was performed for 5 min at 40 W.
Production and concentration of bacteriophage
The phages were produced in 250 ml T-ﬂasks and the
phage lysates were concentrated and puriﬁed according
to the protocol described by Sambrook and Russell
(2001). Brieﬂy, a top-agar layer, containing 3 ml of the
phage solution and 3 ml of the bacterial culture grown
overnight in 90 ml of soft agar, was added to T-ﬂasks
with a thin layer of TSA. After solidiﬁcation, the
T-ﬂasks were incubated at 37 °C overnight. Following
incubation, 90 ml of SM Buffer (5.8 g l−1 NaCl, 2 g l−1
MgSO4.7H2O, 50 ml l−1 1 M Tris–HCl pH 7.5) were
added to the T-ﬂasks and incubated, under shaking
conditions at 5 °C for a minimum of 5 h. The lysate was
concentrated with PEG 8000 and then puriﬁed with
chloroform. The phage solutions in SM Buffer were
stored at 4 °C.
PFU titration of the stock solution
Plaque forming unit (PFU) counting was performed
according to the double agar overlay technique (Kropin-
ski et al. 2008). Brieﬂy, 100 μl of diluted phage solution,
100 μl of bacterial culture, and 3 ml of soft agar were
mixed into a Petri plate containing a thin layer of TSA.
The plates were incubated overnight at 37 °C and then
the PFUs were counted.
Formation of bioﬁlms
Bioﬁlms of single species were formed on 24-well
microplates containing 1 ml of YPD medium and 10 μl of
cellular suspension with an optical density at 600 nm
(OD600) of 1.0, which corresponds to ~1.9 × 10
9 CFU ml−1
for P. aeruginosa ATCC 10145, 1.1 × 109 CFU ml−1 for P.
aeruginosa PAO1 and 1.1 × 107 CFU ml−1 for C. albicans
Table 1. P. aeruginosa and C. albicans strains used in this study.
P. aeruginosa and C. albicans strains Properties and remarks Source/reference
C. albicans CECT 1472 Colección Española de
Cultivos Tipo
P. aeruginosa ATCC 10145 (A+B+ LPS phenotype) wild-type strain, serotype O6 American Type of
Culture Collection
P. aeruginosa PAO1 (A+B+ in LPS phenotype) wild-type strain, serotype O5 University of Guelph,
Canada
P. aeruginosa ATCC 10145_M1 to
P. aeruginosa ATCC10145_M6
Isolates from 24 h of mixed bioﬁlms infection with phage
phiBB-PAA2
This study
Knockout isogenic LPS mutants
derived from P. aeruginosa PAO1:
University of Guelph,
Canada
(1) wbpL Mutant (A−B−), deﬁcient in the initial glycosyltransferase
affecting both B-band and A-band
Rocchetta, Burrows,
et al. (1998)
(2) rmlC Mutant (A−B−), defective in TDP-L-rhamnose biosynthesis, with
truncated outer core
Rahim et al. (2000)
(3) wzy Mutant (A+B−), deﬁcient in O-antigen polymerase for B-band
biosynthesis, produces core-plus-one O-repeat unit
de Kievit et al. (1995)
(4) rmd Mutant (A−B+), deﬁcient in GDP-D-rhamnose biosynthesis
becomes A-band minus, not affecting B-band
Rocchetta, Pacan,
et al. (1998)
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CECT 1472. Bioﬁlms dual species were also formed in
24-microtitre plates in which the wells, containing 1 ml of
YPD medium, were inoculated with 10 μl of each cellular
suspension (OD600 of 1.0). Both bioﬁlms of single and
dual species were formed for 24 and 48 h with the renewal
of medium every 12 h. The plates were incubated at 37 °C
with shaking at 120 rpm in an orbital shaker.
Crystal violet assay
For characterization of bioﬁlms, the total biomass attached
to each well was measured using the crystal violet (CV)
assay as previously described (Silva et al. 2009; Pires
et al. 2011). Brieﬂy, after the wells were washed with a
saline solution (0.9% NaCl (Merck) in distilled water),
methanol (Merck) ﬁxation of the biomass of each well
was done, followed by CV (1% v/v in water, Merck)
staining and acetic acid (33% v/v, Merck) elution. The
eluted stain aliquots from each well were placed in a
96-well microtiter plate and absorbance at 570 nm (A570)
was determined by using an ELISA plate reader.
XTT reduction assay
Quantiﬁcation of the cellular activity of the bioﬁlm
was measured through a reduction assay with
2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylami-
no)carbonyl]-2H-tetrazoliumhydroxide (XTT) using a
previously described method (Silva et al. 2010; Pires
et al. 2011). The wells of a 24-well microtiter plate were
washed with saline solution (0.9% NaCl) and later 1 ml
of XTT solution (200 mg l−1, Sigma) containing PMS
(20 mg l−1, Sigma) was added into each well. The plates
were incubated at 37 °C for 3 h in the dark and then the
absorbance at 490 nm (A490) was read with an ELISA
plate reader in 96-well microtiter plates.
Scanning electron microscopy of the bioﬁlms
Bioﬁlms were also analyzed by scanning electron
microscopy (SEM; S-360, Leo, Cambridge, USA) fol-
lowing standard preparative techniques. Brieﬂy, bioﬁlms
formed on slides cut from the bottom of 24-well micro-
plates were washed with saline solution, dehydrated with
alcohol (20% ethanol for 10 min, 50% ethanol for
10 min, 70% ethanol for 10 min, 95% ethanol for
10 min and 100% ethanol for 20 min) and were allowed
to dry prior to coating with gold.
Infection of bioﬁlms
To investigate the pattern of growth recovery of the
Candida bioﬁlm, once the Pseudomonas bioﬁlm cells
were lysed, phages speciﬁc for the P. aeruginosa strains
to eliminate the bacterial cells from the dual-species
bioﬁlm were used. For this, dual-species bioﬁlms
(P. aeruginosa ATCC 10145 + C. albicans CECT 1472
and P. aeruginosa PAO1 + C. albicans CECT1472)
were, respectively, infected with previously characterized
phages, phiIBB-PAA2 (P. aeruginosa ATCC 10145 host)
and phiIBB-PAP21 (P. aeruginosa PAO1 host) (Pires
et al. 2011).
After bioﬁlm formation for 24 h, all the medium and
planktonic bacteria were removed from each well and the
wells were washed twice with fresh YPD medium. After-
wards, 500 μl of fresh YPD medium and 500 μl of phage
solution or SM buffer, in the case of control experiments,
were added. The multiplicity of infection used in infection
of bioﬁlms was 1. The plates were incubated under
agitation (120 rpm) at 37 °C and samples were taken after
2, 6 and 24 h infection of bioﬁlm for counting the colony
forming units (CFU) and PFUs (number of phages
attached and released from bioﬁlms).
Counts of CFU and PFU in the attached bacteria,
yeast or phages
For both mono- and dual-species bioﬁlms, the microdrop
technique was used to count the CFU that correspond to
the number of viable cells present in the bioﬁlms. First,
the wells of the microplates were washed twice with
saline solution (0.9% NaCl) to remove unattached micro-
organisms and then, 1 ml of fresh saline solution was
added to each well. After this, the bioﬁlm was scraped
with a scraper and the samples were taken, diluted in sal-
ine solution and one drop (10 μl) was placed into a Petri
plate and allowed to run down the plate (Silva et al. 2010;
Pires et al. 2011). Titers of P. aeruginosa were determined
by plating on YPD solid medium supplemented with
amphotericin B (10 μg ml−1) in order to suppress fungal
growth and C. albicans was plated on YPD solid medium
supplemented with tetracycline (50 μg ml−1) to suppress
the growth of P. aeruginosa. The plates were incubated at
37 °C for 16 to 18 h and then the CFUs were counted.
To determine the number of phages attached to the
bioﬁlms, the Small Drop method with some modiﬁca-
tions was used (Mazzocco et al. 2008). Brieﬂy, bioﬁlms
were washed, resuspended in 1 ml of fresh saline
solution and scraped as described for CFU counts. Then,
samples were taken, diluted in SM buffer and 20 μl of
the diluted phage solution were added to 20 μl of the
host solution grown overnight and was incubated for 15–
20 min in order to allow the phage to bind the host.
After this, 20 μl of each sample were placed in an agar
plate and allowed to dry. The plates were incubated
overnight at 37 °C to allow for the PFU counts.
Preparation of lysates of P. aeruginosa
Cultures of P. aeruginosa ATCC 10145 were infected
with phage phiIBB-PAA2 for 24 h. The culture was
centrifuged (9,000 × g, 10 min, 4 °C), the supernatant
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was collected, and the lysates were ﬁltered (0.22 μm) to
remove all non-lysed cells. The ﬁltered lysates were
applied to 24 h old bioﬁlms of C. albicans for the same
24 h conditions as used in the assays for phage infection
of dual-species bioﬁlms.
Isolation of phage-resistant phenotypes of P. aeruginosa
After infection of dual-species bioﬁlm with phage phi-
IBB-PAA2 for 24 h, several colonies of P. aeruginosa
were picked and isolated. Then, the isolated colonies
were tested for their susceptibility to the phages used in
this study – phiIBB-PAA2 and phiIBB-PAP21. In total,
six phenotype variants, named as P. aeruginosa
ATCC_M1 to P. aeruginosa ATCC_M6 were isolated
(these strains are described as M1–M6).
Preparation of LPS
The samples of bacterial LPS were prepared according
to the protocol described by Hitchcock and Brown
(H&B) (Hitchcock & Brown 1983). Brieﬂy, 1 ml of a
bacterial culture at OD600 of 0.45 was centrifuged
(1 min, 10,000 × g) and the pellet was suspended in
250 μl of the lysis buffer (2% w/v SDS, 4% v/v
2-mercaptoethanol, 10% v/v glycerol, 1.0 M Tris–HCl
pH 6.8, bromophenol blue for colour). The lysates were
heated at 100 °C for 30 min, 1.5 μl of 20 mg ml−1
proteinase K (Sigma) were added to them, they were
incubated overnight at room temperature, and centrifuged
for 1 min at 10,000 × g.
SDS-PAGE Western immunoblotting of bacterial LPS
Acrylamide running gels at 12% were prepared accord-
ing to a modiﬁed Laemmli procedure with resolving gels
devoid of SDS (Laemmli 1970). Three μl samples of
H&B LPS, except for the O6 B-band blot in which the
sample used was only 1 μl, were loaded on the acrylam-
ide gel and run at 150 V for 50 min. Blotting was per-
formed for 60 min at 200 mA. Skimmed milk (5%) in
PBS was used to block the nitrocellulose (NC) blots
(Rocchetta & Lam 1997). Primary monoclonal antibodies
(mAb) speciﬁc against P. aeruginosa LPS were from cell
lines of mouse hybridoma, and the supernatants of the
culture of these were used undiluted as described previ-
ously (Emara et al. 1995) to incubate with the NC blots
overnight at room temperature. The mAb used included
MF15-4 (serotype O5 B-band speciﬁc), MF83-1
(serotype O6 B-band speciﬁc), N1F10 (A-band speciﬁc),
5c-101 (outer-core speciﬁc), and 5c-7-4 (inner-core spe-
ciﬁc). Secondary antibodies used were goat anti-mouse
Fab2-alkaline phosphatase conjugated and incubated at
room temperature for 60 min. The blots were developed
with the BCIP/NBT as per the manufacturer’s protocols
(Sigma). The LPS banding patterns were visualized using
the ultrafast silver nitrate-staining method that was
described previously (Fomsgaard et al. 1990).
Results
Bioﬁlm characterization
In mono-species bioﬁlms of P. aeruginosa ATCC 10145,
P. aeruginosa PAO1, and C. albicans CECT 1472,
respectively, no statistical differences could be discerned
in each of these cultures between cultures of 24–48 h
bioﬁlms in terms of viable cells (p > 0.05) and total bio-
mass (p > 0.05) (Figure 1A and B). The analysis of the
metabolic activity through XTT reduction assays showed
that bioﬁlms of both 24 and 48 h P. aeruginosa ATCC
10145 exhibited similar activities while bioﬁlms of
P. aeruginosa PAO1 had lower metabolic activity after
48 h. On the contrary, 48 h old bioﬁlms of C. albicans
appeared to be metabolically more active than the 24 h
old bioﬁlms (Figure 1C).
In comparison with mono-species bioﬁlms of
C. albicans (Figure 1A), the formation of mixed bioﬁlms
showed that P. aeruginosa caused a signiﬁcant inhibition
of proliferation of C. albicans. This inhibition of
C. albicans was greater in the presence of P. aeruginosa
ATCC 10145 which resulted in ~2- and 3-log reduction
in the number of viable cells of C. albicans in 24 and
48 h old bioﬁlms (Figure 1A), respectively, than in the
presence of P. aeruginosa PAO 1 strain. However,
there was no inhibition of C. albicans in a planktonic
co-culture with P. aeruginosa, since both microorganisms
showed similar growth rates when compared to their
respective mono-species cultures (data not shown).
Neither of the two wild-type strains of P. aeruginosa
was inﬂuenced by the presence of C. albicans, since the
CFU of the viable cells of P. aeruginosa present in dual-
species bioﬁlms were similar to the numbers observed in
the mono-species bioﬁlms of P. aeruginosa (Figure 1A).
The total biomass in dual-species bioﬁlms was lower in
the 48 h bioﬁlms; this is due to the reduction observed
in the number of cells of C. albicans (Figure 1B).
However, there was no statistical difference in the meta-
bolic activity between 24 and 48 h-old mixed bioﬁlms
(Figure 1C).
Examination of the bioﬁlms by SEM showed that
there was a clear reduction in the numbers of cells of
C. albicans in dual-species bioﬁlms compared to
mono-species bioﬁlms of C. albicans bioﬁlms (Figure 2).
Furthermore, on examining the 48 h-old dual-species
bioﬁlms formed by P. aeruginosa ATCC 10145 and
C. albicans CECT 1472, it was found that the bioﬁlm of
Pseudomonas covered the entire surface even masking a
few cells of C. albicans. Whereas in the bioﬁlms formed
by P. aeruginosa PAO1 and C. albicans CECT 1472, the
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Candida cells were not covered by Pseudomonas. The
results obtained clearly showed that P. aeruginosa
inhibited the formation of bioﬁlms of C. albicans.
Infection of bioﬁlms with phage
Both the phages, phiIBB-PAA2 and phiIBB-PAP21, can
be considered effective against their target Pseudomonas
cells in the dual-species bioﬁlms, achieving an ~2- and
1.5-log reduction, respectively, in the number of viable
cells of P. aeruginosa, 6 h post infection (Figure 3). As
expected, the reduction in the mixed bioﬁlms of P. aeru-
ginosa caused a reciprocal increase in the amount of
cells of C. albicans. However, at 24 h post infection of
the mixed bioﬁlms, an increase in the number of viable
cells of P. aeruginosa, ~1.5 log for P. aeruginosa ATCC
10145 strain and 1 log for P. aeruginosa PAO1, was
observed as compared to the CFU numbers 6 h post
infection (Figure 3A and B). This suggests that the cells
of P. aeruginosa acquired resistance to the phages
between 6 and 24 h of infection of the bioﬁlm. This
increase in P. aeruginosa at 24 h of phage infection did
not appear to interfere with the growth of the bioﬁlm of
C. albicans and accordingly a similar increase in the
number of C. albicans was observed. An increase of 0.5
and 1 log in the CFU of C. albicans in the presence of
P. aeruginosa PAO1 and ATCC 10145, respectively, at
the 24 h time point was observed as compared with the
initial time point of phage infection (Figure 3A and B).
This increase in the number of cells of C. albicans after
phage infection was also substantiated by the results
from SEM analysis (Figure 3E and F). Interestingly, after
infecting the dual-species bioﬁlm with phage phiIBB-
PAA2, the cells of C. albicans changed from the yeast to
the ﬁlamentous form (Figure 3E). This morphological
change, observed at the 24 and 48 h time points, was
not observed in mono-species bioﬁlms of C. albicans
(Figure 2A and 2B).
To understand the reasons behind non-inhibition of
the bioﬁlms of C. albicans in the presence of cells of
P. aeruginosa after 24 h of phage infection of the
dual-species bioﬁlm, the hypothesis that the lysates of
P. aeruginosa served to provide nutrients for the prolifer-
ation of C. albicans was tested. However, no increase in
the growth of bioﬁlm of C. albicans could be discerned
due to the supplementation with the sonicated and phage
lysates of P. aeruginosa (Figure 4). The tested number
of viable cells of C. albicans in the bioﬁlms
supplemented with both types of lysates of P. aeruginosa
was 0.5 log lower than that in 48 h old bioﬁlms of
C. albicans. Hence, these results do not support the
hypothesis stated above.
The hypothesis that the resurgence in the growth of
cells of C. albicans in the phage-infected dual-species
bioﬁlms was caused by the emergence of mutant
phenotypes of phage-resistant P. aeruginosa, which are
not able to inhibit the proliferation of the bioﬁlms of
C. albicans. Four of these strains (M2, M4, M5 and M6)
showed resistance to the phage phiIBB-PAA2; and only
strain M2 was resistant to phage phiIBB-PAP21 also
(Table 2). Dual-species bioﬁlms with C. albicans were
once again grown with these P. aeruginosa ATCC
10145-derived phenotype variants (Figure 5). Further-
more, four deﬁned mutant strains of P. aeruginosa PAO1
LPS (wzy, rmd, wbpL and rmlC) were also used to
assess the role of LPS in assaying the bioﬁlms of
Figure 1. Quantitative assessments of the growth of bioﬁlm
of single (S) and mixed (M) cultures. Mono-species bioﬁlms
are those of P. aeruginosa ATCC 10145 (PA ATCC), PAO1
(PA PAO1), and C. albicans CECT 1472 (CA), respectively.
Dual-species bioﬁlms are composed of CA with PA ATCC or
PA PAO1. Quantitative measurements were made at 24 h
(black bar) and 48 h (grey bar). (A) Number of viable cells
present in the bioﬁlms; (B) biomass quantiﬁcation by
measuring the intensity of CV stain at A570; (C) evaluation of
the metabolic activity of the bioﬁlm by XTT reduction assay
by making measurements at A490. Standard deviations are
based on two independent experiments, each being performed
in triplicate. *Signiﬁcantly different (p < 0.05) from the number
of cells in mono-species bioﬁlms.
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C. albicans (Figure 5). These strains were also tested for
susceptibility against phages, phiIBB-PAA2 and phiIBB-
PAP21, (Table 2) and it was observed that all of them
were susceptible to phage phiIBB-PAP21; note that the
wild-type strain P. aeruginosa PAO1 was also suscepti-
ble to this phage. Nevertheless, only the wild-type strain,
wzy and rmd mutant strains, were susceptible to phage
phiIBB-PAA2. The other two strains (wbpL and rmlC)
that have a shorter chain of B-band LPS were resistant
to this phage.
Dual-species bioﬁlms formed by the different
P. aeruginosa ATCC 10145-derived phenotypes variants
revealed that most of them could co-inhabit better with
C. albicans than the parental strain ATCC 10145
(Figure 5). This has led to the observed increases in the
growth of C. albicans at 24 h post phage infection of
the dual-species bioﬁlms. This variation is more
pronounced after 48 h of formation of the bioﬁlm
(Figure 5B) since the cells in the bioﬁlm of C. albicans
increased by more than 1 log in the mixed cultures with
the M1–M6 strains as compared to co-culture of
bioﬁlms of C. albicans grown with the parental strain,
P. aeruginosa ATCC 10145. Nevertheless, the number
of cells of C. albicans in these bioﬁlms is still ~1 log
lower than the numbers obtained in mono-species bio-
ﬁlms of C. albicans. A similar result was obtained with
dual-species bioﬁlms of mutants of P. aeruginosa PAO1
LPS and C. albicans. Although the number of cells of
C. albicans cells after 24 h of formation of the bioﬁlm
with these mutants is slightly higher compared to the
parental strain P. aeruginosa PAO1 (Figure 5A), this
increase is more signiﬁcant after 48 h of formation of
mixed bioﬁlm mainly with the mutant rmlC, which has
a defect in the biosynthesis of core oligosaccharide and
produces the shortest LPS chain among all of the
mutants tested (consisting of an inner core and lipid A
region) (Figure 5B). The number of cells of C. albicans
in dual-species bioﬁlm with this LPS-defective strain is
Figure 2. Examination using a SEM of mono- and dual-species bioﬁlms. 24 h (A) and 48 h (B) old bioﬁlms formed by C. albicans
CECT 1472; (C) 48 h old dual-species bioﬁlms formed by P. aeruginosa ATCC 10145 and C. albicans CECT 1472; (D) 48 h old
dual-species bioﬁlm formed by P. aeruginosa PAO1 and C. albicans CECT 1472.
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only 0.5 log lower compared with 48 h mono-species
bioﬁlms of C. albicans (Figure 1).
The differences in the phenotype of LPS among the
different strains of P. aeruginosa including the PAO1
Figure 3. Phage infection of dual-species bioﬁlm with phiIBB-PAA2 and phiIBB-PAP21. CFU counts of the viable cells of P. aeru-
ginosa ATCC 10145 and C. albicans CECT 1472 (A) or P. aeruginosa PAO1 and C. albicans CECT 1472 (B) present in mixed bio-
ﬁlms before (0 h) and after infection (2, 6 and 24 h); PFU counts of phages attached to the mixed bioﬁlms after infection (C); and of
phages released from bioﬁlms (D); SEM images of: 24 h old bioﬁlms of P. aeruginosa ATCC 10145 and C. albicans CECT 1472
after 24 h of infection with phage phiIBB-PAA2 (E); and 24 h old bioﬁlms of P. aeruginosa PAO1 and C. albicans CECT 1472 after
24 h of infection with phage phiIBB-PAP21 (F). Error bars represent standard deviations from two independent experiments per-
formed in triplicate; *signiﬁcantly different (p < 0.05) from the number of cells of the bioﬁlm at 0 h; ψsigniﬁcantly different
(p < 0.05) from the number of phages at the beginning of experiment.
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wild type and the deﬁned LPS mutants, wzy, wbpL, and
rmlC, are clearly visible (Figure 6). The wzy mutant is
devoid of B-band LPS, while the wbpL mutants showed
faster migrating bands of the core oligosaccharide
reactive with mAb 5c-7-4 (inner-core speciﬁc) and no
reaction to mAb MF15-4 (B-band speciﬁc against
serotype O5) or 5c-101 (outer-core speciﬁc) indicative of
a defect in the outer-core region. Accordingly, the rmlC
mutant which causes the lowest inhibition in the cells of
C. albicans exhibits a LPS banding pattern that is devoid
of both A-band and B-band LPS and has a fast migrating
band indicative of a truncated LPS core (Figure 6, panel
A). The rmd mutant is defective in A-band LPS biosyn-
thesis, hence, as expected did not show any defect in the
production of high-molecular-weight (HMW) B-band
LPS (Figure 6, panel A). These results veriﬁed the
defects in the LPS of the mutants as were reported in
previous studies by the Lam laboratory. Therefore, the
LPS banding patterns from these mutants are useful
standards for characterizing the phenotype of the LPS in
the M1–M6 mutants. Among the ATCC 10145-derived
M1–M6 mutants, the M2 mutant (Figure 6B) is the only
strain that is resistant to both phiIBB-PAP21 and
phiIBB-PAA2 phages. M2 exhibited a LPS banding
pattern that showed a lack of HMW bands, indicating
defects in the production of A-band and B-band LPS. In
addition, M2 LPS also showed a fast-migrating core
oligosaccharide band indicating truncation in the LPS
core. Due to truncation of the LPS core, neither A-band
nor B-band O-polysaccharides could be assembled onto
the core, hence HMW bands of A-band and B-band
polysaccharide that are linked to carriers of undecaprenol
lipid still remain, as observed in the two immunoblots
that were probed with mAb MF83-1 (B-band speciﬁc
against serotype O6) and mAb N1F10 (A-band speciﬁc).
Figure 5. Dual-species bioﬁlms formed by P. aeruginosa
ATCC 10145 (M1–M6) or PAO1 mutant strains with C. albicans
CECT 1472. Dual-species bioﬁlms of C. albicans CECT 1472
formed with P. aeruginosa ATCC and PAO1 phenotypes for 24 h
(A) and 48 h (B). Error bars represent standard deviations from
two independent experiments performed in triplicate; *signiﬁ-
cantly different (p < 0.05) from the number of cells in the bioﬁlm
of wild-type strain of P. aeruginosa ATCC 10145; ψsigniﬁcantly
different (p < 0.05) from the number of cells in the bioﬁlm of
wild-type strain of P. aeruginosa PAO1; †signiﬁcantly different
(p < 0.05) from the number of cells of bioﬁlm of C. albicans
CECT 1472 in mixed bioﬁlms with wild-type strains of
P. aeruginosa (ATCC 10145 or PAO1).
Table 2. Lytic spectra of the 2 phages against the P. aeruginosa ATCC and PAO1 mutant phenotypes.
P. aeruginosa ATCC 10145 P. aeruginosa PAO 1
Wild type M1 M2 M3 M4 M5 M6 Wild type wbpL rmlC wzy rmd
Phage phiIBB-PAA2 + + − + − − − + − − + +
Phage phiIBB-PAP21 + + − + + + + + + + + +
(+ susceptible; − not susceptible).
Figure 4. Comparison of 48 h old bioﬁlms of C. albicans
CECT 1472 with bioﬁlms of C. albicans formed over 24 h and
exposed for 24 h to P. aeruginosa phage or sonicated cultured
lysates. Error bars represent standard deviations from two inde-
pendent experiments performed in triplicate; *signiﬁcantly dif-
ferent (p < 0.05) from 48 h bioﬁlms of old C. albicans.
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The nature of these undecaprenol-linked polysaccharide
bands has been veriﬁed due to their sensitivity to phenol
as demonstrated in an earlier study by the authors when
LPS was prepared using the standard phenol and hot
water method (Rocchetta & Lam 1997). In contrast, the
LPS banding patterns from M1 and M3-M6 were all
quite similar to the LPS banding pattern of wild-type
strain of P. aeruginosa ATCC 10145 (Figure 6B) indicat-
ing that they have very distinct phenotypes of LPS as
compared to M2.
Figure 6. SDS-PAGE and Western immunoblotting analysis of LPS from P. aeruginosa PAO1 and PAO1-derived isogenic LPS
mutant strains (Panel A) and P. aeruginosa ATCC 10145 and M1–M6 phenotype variants (Panel B). Silver stained SDS-PAGE gels
were displayed at the top of each of panels A and B, followed by immunoblots that were probed with mAbs, MF15-4 (B-band
speciﬁc against serotype O5), 5c-101 (outer-core speciﬁc), N1F10 (A-band speciﬁc), and 5c-7-4 (outer-core speciﬁc), and MF83-1
(B-band speciﬁc against serotype O6, which is the serotype determined for strain ATCC 10145). Note that in panel A, both mAb
MF15-4 and 5c-101 were used simultaneously on one of the blots to demonstrate the truncation in the LPS core in wbpL and rmlC
mutants and the lack of B-band LPS in wzy, wbpL, and rmlC mutants. On Panel B, only a B-band speciﬁc mAb MF83-1 was used
and not mAb 5c-101, as the latter mAb is speciﬁc against the terminal glucose of the outer core, which is absent in O6 strains. Note
the lack of high-molecular-weight bands and the fast migrating core-oligosaccharide band in the LPS sample from M2.
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Discussion
C. albicans and P. aeruginosa are frequently involved in
severe infections associated with polymicrobial bioﬁlms
formed on indwelling devices (Pierce 2005). It has been
reported that the virulence of C. albicans is inﬂuenced
by the presence of P. aeruginosa as this bacterium exhib-
its antifungal behavior against Candida spp. (Bandara,
Yau, et al. 2010; Holcombe et al. 2010). However, the
interaction between Candida spp. and P. aeruginosa in a
polymicrobial bioﬁlm is not fully understood. In the
present work, inhibition in the development and ﬁlamen-
tation of C. albicans was observed in mixed bioﬁlms
with P. aeruginosa. After 24 and 48 h of formation of
the mixed bioﬁlm (Figure 1), the amount of viable cells
of C. albicans was signiﬁcantly reduced compared with
single bioﬁlms of C. albicans. However, the substantial
reduction in the count of C. albicans reported by Band-
ara et al. after 48 h of incubation of mixed bioﬁlm with
P. aeruginosa was not observed in the authors’ study
(Bandara, Yau, et al. 2010). Interestingly, no signiﬁcant
changes occurred in the number of viable cells of P.
aeruginosa between 24 and 48 h dual-species and mono-
species bioﬁlms of P. aeruginosa. Similar results were
observed by other authors who showed that P. aerugin-
osa forms a dense bioﬁlm on the ﬁlaments of C. albi-
cans; presumably this superimposed bioﬁlm of P.
aeruginosa is responsible for the destruction of the fun-
gus (Hogan & Kolter 2002).
In recent years, many studies have shown the
potential of using phages as antibacterial agents for the
treatment of infectious diseases (Weber-Dabrowska et al.
2001, 2003; Matsuzaki et al. 2005; Hanlon 2007; McVay
et al. 2007) and for control of bacterial bioﬁlm (Tait
et al. 2002; Curtin & Donlan 2006; Sillankorva et al.
2008; Donlan 2009). The phages used in this study were
previously isolated from hospital efﬂuents and were
shown to be capable of infecting a variety of strains of
P. aeruginosa that are resistant to antibiotics and also to
control both exponential- and stationary-phase cells
(Pires et al. 2011). The infection of dual-species bioﬁlms
with phage resulted in a signiﬁcant reduction of viable
cells of both P. aeruginosa ATCC 10145 and P. aerugin-
osa PAO1 as early as 2–6 h post infection. However,
after the initial reduction in the count of bacterial cells,
the number of viable cells of P. aeruginosa was found to
increase at the 24 h time point (Figure 3). This could be
interpreted as the cells of P. aeruginosa acquiring resis-
tance to the respective phages. On the other hand, the
number of cells of C. albicans present in the dual-spe-
cies bioﬁlm steadily increased from the time of phage
infection and achieved signiﬁcantly higher numbers of
viable cells after infection of the bioﬁlm for 24 h. These
results suggest that the surviving cells of P. aeruginosa
after the phage attack have acquired changes in their
phenotype and exhibited a diminished ability to inhibit
the growth of bioﬁlm of C. albicans. Another possible
explanation is that, after phage infection, the reduction in
the number of cells of P. aeruginosa present in the bio-
ﬁlm increased the source of nutrients available for the
proliferation of C. albicans. However, after adding the
lysates of P. aeruginosa to bioﬁlms of C. albicans (Fig-
ure 4), it was observed that the results did not support
this hypothesis. Nevertheless, the results showed a slight
decrease in the bioﬁlms of C. albicans, suggesting that
lysates containing intracellular soluble material from P.
aeruginosa, like LPS, inhibit the proliferation of bioﬁlm.
The phenotype variants of P. aeruginosa ATCC
10145, M1–M6, isolated during the course of this work,
the majority of which (4 out of 6) were phage-resistant
(Table 2), were found to exhibit a signiﬁcantly reduced
ability to inhibit the proliferation of bioﬁlm of C. albicans
as compared to the co-culture experiments using the
wild-type strain of the parental P. aeruginosa ATCC
10145. Since several studies have shown that LPS mole-
cules are the receptors of T7-like phages and changes in
the LPS structure is a major cause for bacterial resistance
to phages (Wright et al. 1980), one of the explanations for
the reduced inﬂuence of the phage-resistant phenotypes
P. aeruginosa on the growth of C. albicans is a possible
modiﬁcation of the LPS, an integral component of the cell
envelopes and a major factor for virulence (Lam et al.
2011). Thus, the LPS of these ATCC-10145-derived
phenotype variants were extracted and analyzed together
with a number of deﬁned LPS knockout mutant strains,
provided by one of the co-authors, from the collection of
strains of the University of Guelph. Among the ATCC
10145-derived phentoype variants of P. aeruginosa that
were isolated post phage infection, most of these strains
exhibit an LPS banding proﬁle in SDS-PAGE and Western
immunoblotting analysis (Figure 6) that was quite similar
to the pattern observed in the parental ATCC strain. Only
the LPS banding pattern of the P. aeruginosa ATCC_M2
strain, which was resistant to both the phages tested,
revealed a signiﬁcant difference in the reduction of the
visible A-band or B-band LPS and a faster migrating band
of the core oligosaccharide. It has been reported that
bacterial LPS have a signiﬁcant effect on the formation of
bioﬁlm by Candida species (Bandara et al. 2009;
Bandara, Lam, et al. 2010). According to Bandara et al.
(2013) bacterial LPS alter the gene expression of
C. albicans during the development of the bioﬁlm,
inﬂuencing directly the proliferation of the bioﬁlm and
formation of hyphae. The observation revealed that the
mutant rmlC, which was truncated at the core oligosaccha-
ride and therefore lacking the outer core region and the
chains of both A-band or B-band O polysaccharide, was
the one exhibiting the lowest inhibition in the proliferation
of C. albicans. Therefore, these observations are in good
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agreement with observations that were made in the
previous study (Bandara, Lam, et al. 2010). Nevertheless,
as shown in this work the phage-resistant phenotypes with
the exception of M2 did not exhibit any modiﬁcation in
their LPS and yet they did not inhibit the formation of bio-
ﬁlms of C. albicans compared to the wild-type strains. It
was therefore hypothesized that the phage-resistant pheno-
types have alterations in their surface receptors as pili, ﬂa-
gella or surface proteins which have been previously
described as phage receptors (Kropinski 2008; Ceyssens
et al. 2011; Kim et al. 2012). These receptors may also be
the cause of the inhibition of proliferation of bioﬁlm of C.
albicans. Further experiments are needed to conﬁrm this
hypothesis.
In conclusion, the work described here showed that
P. aeruginosa effectively inhibits the proliferation of
bioﬁlms of C. albicans due to the presence of bacterial
LPS that exert suppressive effects towards the cells of
C. albicans. Consequently, C. albicans is able to co-
inhabit better with mutant strains of P. aeruginosa,
which only contain the truncated core and lipid-A region
of the LPS chain. Hence, the data showed a correlation
between the inhibition of the formation of bioﬁlm of
C. albicans and the composition of the LPS chain of
P. aeruginosa.
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